论文部分内容阅读
目的研究胸腔镜下肺癌根治术治疗早期非小细胞肺癌(NSCLC)的临床效果。方法 65例早期NSCLC患者,按照临床医治方案分成对照组(31例)和实验组(34例)。对照组行常规开胸肺癌根治术,实验组行胸腔镜下肺癌根治术医治,比较两组手术相关指标及术后并发症情况。结果实验组术中出血量(171.15±12.31)ml、镇痛时间(1.72±0.56)d、引流管留置时间(2.13±1.52)d、住院时间(7.59±3.12)d,均优于对照组的(284.65±53.24)ml、(4.25±1.94)d、(4.85±1.34)d、(16.48±5.64)d,差异有统计学意义(P<0.05);实验组并发症发生率为5.88%,显著低于对照组的25.81%,差异有统计学意义(P<0.05)。结论早期NSCLC行胸腔镜下肺癌根治术医治可取得良好效果,且安全性高,可被临床推广应用。
Objective To study the clinical effects of thoracoscopic radical resection of lung cancer in the treatment of early non-small cell lung cancer (NSCLC). Methods Sixty-five patients with early stage NSCLC were divided into control group (31 cases) and experimental group (34 cases) according to clinical treatment plan. Control group underwent conventional thoracotomy for radical resection of lung cancer. The experimental group underwent thoracoscopic radical resection of lung cancer. The operation-related indexes and postoperative complications were compared between the two groups. Results The blood loss (171.15 ± 12.31) ml, analgesic time (1.72 ± 0.56) days, drainage tube indwelling time (2.13 ± 1.52) days and hospitalization time (7.59 ± 3.12) days in experimental group were significantly higher than those in control group (284.65 ± 53.24) ml, (4.25 ± 1.94) d, (4.85 ± 1.34) d and (16.48 ± 5.64) d respectively, the difference was statistically significant (P <0.05). The incidence of complications in the experimental group was 5.88% Lower than 25.81% of the control group, the difference was statistically significant (P <0.05). Conclusions The treatment of thoracoscopic radical resection of lung cancer in early stage of NSCLC can achieve good results and is safe and can be widely applied in clinical practice.